US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

2.22

-0.1400-5.93%

Post-market: 2.220.00000.00%19:12 EDT

Volume:71.44K

Turnover:160.12K

Market Cap:8.44M

PE:-0.31

High:2.35

Open:2.34

Low:2.18

Close:2.36

52wk High:15.75

52wk Low:2.06

Shares:3.80M

Float Shares:3.78M

Volume Ratio:0.80

T/O Rate:1.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.1480

EPS(LYR):-11.3245

ROE:-302.25%

ROA:-97.46%

PB:1.58

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Alzamend Neuro Inc Issues 361743 Shares of Common Stock Upon Conversion of Series B Preferred

Director’s Major Stock Sale Shakes Up Alzamend Neuro!

Alzamend Neuro Inc. Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares

Alzamend Neuro Inc. Issues 300,000 Common Shares Upon Conversion of Series B Preferred Stock

Alzamend Neuro Is Maintained at Buy by Ascendiant Capital

U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern Trust

Alzamend Neuro Inc : Ascendiant Capital Markets Cuts Target Price to $42 From $45

THOMSON REUTERS

Director and 10% Owner Milton C III Ault Reports Disposal of Alzamend Neuro Inc. Common Shares

Maxim Group Sticks to Their Hold Rating for Alzamend Neuro (ALZN)

Alzamend Neuro Q1 EPS $(1.28) Misses $(0.69) Estimate

Alzamend Neuro Inc. Reports No Revenue for Quarter Ending July 31, 2025; Net Loss Per Share at $1.28

Alzamend Neuro Inc expected to post a loss of 69 cents a share - Earnings Preview

Alzamend Neuro Is Maintained at Buy by Ascendiant Capital

Alzamend Neuro Inc. Issues 243,429 Shares of Common Stock in Conversion of Series B Convertible Preferred Stock

Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares of Alzamend Neuro Inc

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro Inc. Reports No Revenue, Net Loss Narrows by 49.9%, EPS Improves by $121.27

Alzamend Neuro Inc. Eliminates Series A Preferred Stock in Bylaw Amendment

Press Release: Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALZN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALZN\",,,,,undefined,":{"symbol":"ALZN","market":"US","secType":"STK","nameCN":"Alzamend Neuro, Inc","latestPrice":2.22,"timestamp":1760731200000,"preClose":2.36,"halted":0,"volume":71435,"hourTrading":{"tag":"盘后","latestPrice":2.22,"preClose":2.22,"latestTime":"19:12 EDT","volume":780,"amount":1731.26,"timestamp":1760742732584},"delay":0,"floatShares":3784500,"shares":3801600,"eps":-7.148012,"marketStatus":"Market Closed","change":-0.14,"latestTime":"10-17 16:00:00 EDT","open":2.34,"high":2.3499,"low":2.18,"amount":160117.166391,"amplitude":0.071992,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.148012,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"listingDate":1623729600000,"exchange":"NASDAQ","adjPreClose":2.36,"preHourTrading":{"tag":"盘前","latestPrice":2.26,"preClose":2.36,"latestTime":"09:15 EDT","volume":138,"amount":310.52000999999996,"timestamp":1760706912060},"postHourTrading":{"tag":"盘后","latestPrice":2.22,"preClose":2.22,"latestTime":"19:12 EDT","volume":780,"amount":1731.26,"timestamp":1760742732584},"volumeRatio":0.7978409199829699,"impliedVol":1.3738,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALZN\",,,,,undefined,":{"symbol":"ALZN","floatShares":3784500,"roa":"-97.46%","roe":"-302.25%","lyrEps":-11.324523,"volumeRatio":0.7978409199829699,"shares":3801600,"dividePrice":0,"high":2.3499,"amplitude":0.071992,"preClose":2.36,"low":2.18,"week52Low":2.06,"pbRate":"1.58","week52High":15.75,"institutionHeld":0,"latestPrice":2.22,"eps":-7.148012,"divideRate":0,"volume":71435,"delay":0,"ttmEps":-7.148012,"open":2.34,"prevYearClose":10.44,"prevWeekClose":2.18,"prevMonthClose":2.38,"prevQuarterClose":2.38,"fiveDayClose":2.18,"twentyDayClose":2.4,"sixtyDayClose":2.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-10","symbol":"ALZN","fiscalQuarterEnding":"2025/07","expectedEps":-3.69,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1757476800000,"reportTimeType":"post","actualEps":-1.28},{"market":"US","date":"2025-07-22","symbol":"ALZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753156800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-12","symbol":"ALZN","defaultRemindTime":1747056600000,"type":"split","dateTimestamp":1747022400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2025-03-10","symbol":"ALZN","fiscalQuarterEnding":"2025/01","expectedEps":-0.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2024-12-11","symbol":"ALZN","fiscalQuarterEnding":"2024/10","expectedEps":-2.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733893200000,"reportTimeType":"post","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALZN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1740628800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALZN","date":"2025-10-16","current":-0.310576,"percent":0.599631,"low":-227.195707,"twenty":-9.731754,"median":-2.498119,"eighty":-0.569409,"high":-0.165749,"avg":-10.961689,"sd":24.059657,"marketCap":7980477},"quantilePoints":[{"date":"2021-06-11","current":-64.165808,"twenty":-64.165808,"median":-64.165808,"eighty":-64.165808,"marketCap":323814290},{"date":"2021-06-18","current":-151.968684,"twenty":-174.183375,"median":-160.888219,"eighty":-84.146558,"marketCap":766913610},{"date":"2021-06-25","current":-144.73208,"twenty":-169.807754,"median":-144.73208,"eighty":-136.65401,"marketCap":730393915},{"date":"2021-07-02","current":-122.517389,"twenty":-169.807754,"median":-145.910131,"eighty":-129.249113,"marketCap":618286942},{"date":"2021-07-09","current":-103.16368,"twenty":-163.210664,"median":-140.188166,"eighty":-108.650035,"marketCap":520617988},{"date":"2021-07-16","current":-103.836853,"twenty":-153.887226,"median":-129.249113,"eighty":-104.240756,"marketCap":524015169},{"date":"2021-07-23","current":-96.431956,"twenty":-150.756974,"median":-117.384448,"eighty":-96.56659,"marketCap":486646178},{"date":"2021-07-30","current":-74.797882,"twenty":-147.761356,"median":-107.875887,"eighty":-88.25291,"marketCap":377472523},{"date":"2021-08-06","current":-71.417558,"twenty":-145.203301,"median":-104.089292,"eighty":-78.127867,"marketCap":360413489},{"date":"2021-08-13","current":-59.743534,"twenty":-142.03939,"median":-102.827094,"eighty":-74.045435,"marketCap":301499745},{"date":"2021-08-20","current":-55.62329,"twenty":-139.481335,"median":-94.749024,"eighty":-69.872466,"marketCap":280706659},{"date":"2021-08-27","current":-49.614601,"twenty":-137.125231,"median":-88.353886,"eighty":-63.350024,"marketCap":250383409},{"date":"2021-09-03","current":-53.734845,"twenty":-130.730092,"median":-83.389239,"eighty":-57.202717,"marketCap":271176495},{"date":"2021-09-10","current":-50.644662,"twenty":-125.210079,"median":-77.164368,"eighty":-56.481674,"marketCap":255581681},{"date":"2021-09-17","current":-37.342199,"twenty":-119.488113,"median":-74.679417,"eighty":-53.391491,"marketCap":225908430},{"date":"2021-09-24","current":-34.469722,"twenty":-117.367619,"median":-72.566282,"eighty":-51.777729,"marketCap":208530859},{"date":"2021-10-01","current":-41.363667,"twenty":-112.554436,"median":-69.872466,"eighty":-50.232638,"marketCap":250237031},{"date":"2021-10-08","current":-36.62408,"twenty":-108.481742,"median":-67.554829,"eighty":-40.789171,"marketCap":221564037},{"date":"2021-10-15","current":-34.326098,"twenty":-106.563201,"median":-60.086887,"eighty":-38.002869,"marketCap":207661980},{"date":"2021-10-22","current":-30.304631,"twenty":-104.88027,"median":-57.425897,"eighty":-37.514548,"marketCap":183333380},{"date":"2021-10-29","current":-30.735502,"twenty":-104.038805,"median":-56.653351,"eighty":-35.561263,"marketCap":185940016},{"date":"2021-11-05","current":-41.363667,"twenty":-103.432949,"median":-56.052482,"eighty":-34.843144,"marketCap":250237031},{"date":"2021-11-12","current":-33.607979,"twenty":-102.961728,"median":-53.734845,"eighty":-34.469722,"marketCap":203317587},{"date":"2021-11-19","current":-31.166374,"twenty":-99.090987,"median":-52.447268,"eighty":-33.780328,"marketCap":188546651},{"date":"2021-11-26","current":-32.602612,"twenty":-96.532932,"median":-51.760562,"eighty":-33.177108,"marketCap":197235437},{"date":"2021-12-03","current":-28.437521,"twenty":-95.085611,"median":-51.331369,"eighty":-32.660062,"marketCap":172037958},{"date":"2021-12-10","current":-31.597245,"twenty":-91.315845,"median":-46.925373,"eighty":-32.516438,"marketCap":191153287},{"date":"2021-12-17","current":-26.241096,"twenty":-88.555838,"median":-41.363667,"eighty":-31.884493,"marketCap":217683377},{"date":"2021-12-23","current":-23.0279,"twenty":-88.25291,"median":-39.927428,"eighty":-31.597245,"marketCap":191028269},{"date":"2021-12-31","current":-20.350237,"twenty":-87.108517,"median":-38.13213,"eighty":-30.936576,"marketCap":168815680},{"date":"2022-01-07","current":-20.56445,"twenty":-83.84363,"median":-37.916695,"eighty":-30.735502,"marketCap":170592687},{"date":"2022-01-14","current":-19.172066,"twenty":-81.859576,"median":-37.701259,"eighty":-30.362081,"marketCap":159042140},{"date":"2022-01-21","current":-16.28019,"twenty":-78.770199,"median":-37.414011,"eighty":-29.012016,"marketCap":135052544},{"date":"2022-01-28","current":-15.423338,"twenty":-75.558538,"median":-35.618713,"eighty":-27.740587,"marketCap":127944515},{"date":"2022-02-04","current":-14.566486,"twenty":-74.797882,"median":-35.475089,"eighty":-25.705563,"marketCap":120836486},{"date":"2022-02-11","current":-14.994912,"twenty":-74.679417,"median":-34.75697,"eighty":-23.0279,"marketCap":124390501},{"date":"2022-02-18","current":-13.709634,"twenty":-74.385557,"median":-34.39791,"eighty":-21.528409,"marketCap":113728458},{"date":"2022-02-25","current":-12.317249,"twenty":-73.025069,"median":-34.038851,"eighty":-20.950034,"marketCap":102177911},{"date":"2022-03-04","current":-12.317249,"twenty":-72.495084,"median":-33.607979,"eighty":-20.264552,"marketCap":102177911},{"date":"2022-03-11","current":-10.282225,"twenty":-71.62357,"median":-32.939333,"eighty":-18.893589,"marketCap":85296343},{"date":"2022-03-18","current":-10.443205,"twenty":-70.181484,"median":-32.88986,"eighty":-16.644352,"marketCap":101815963},{"date":"2022-03-25","current":-11.367382,"twenty":-69.872466,"median":-32.674424,"eighty":-16.087398,"marketCap":110826226},{"date":"2022-04-01","current":-10.720458,"twenty":-69.460442,"median":-32.602612,"eighty":-15.401917,"marketCap":104519042},{"date":"2022-04-08","current":-10.350787,"twenty":-66.473265,"median":-31.884493,"eighty":-14.887805,"marketCap":100914937},{"date":"2022-04-14","current":-9.611445,"twenty":-64.800374,"median":-31.740869,"eighty":-14.780699,"marketCap":93706727},{"date":"2022-04-22","current":-8.354564,"twenty":-61.718455,"median":-31.597245,"eighty":-14.030953,"marketCap":81452771},{"date":"2022-04-29","current":-9.731754,"twenty":-59.880875,"median":-31.238186,"eighty":-12.745675,"marketCap":94879675},{"date":"2022-05-06","current":-9.432168,"twenty":-58.404455,"median":-30.807314,"eighty":-12.573699,"marketCap":91958870},{"date":"2022-05-13","current":-8.943673,"twenty":-57.408729,"median":-30.735502,"eighty":-12.130465,"marketCap":87196282},{"date":"2022-05-20","current":-8.729956,"twenty":-56.928034,"median":-30.591879,"eighty":-11.422833,"marketCap":85112650},{"date":"2022-05-27","current":-8.985653,"twenty":-56.653351,"median":-30.161007,"eighty":-11.246184,"marketCap":87605567},{"date":"2022-06-03","current":-9.302412,"twenty":-56.58468,"median":-29.15564,"eighty":-10.757425,"marketCap":90693807},{"date":"2022-06-10","current":-8.860657,"twenty":-56.481674,"median":-28.437521,"eighty":-10.37032,"marketCap":86386921},{"date":"2022-06-17","current":-8.340685,"twenty":-56.13832,"median":-27.514558,"eighty":-10.217416,"marketCap":81317463},{"date":"2022-06-24","current":-9.028587,"twenty":-55.382942,"median":-26.669522,"eighty":-10.081505,"marketCap":88024154},{"date":"2022-07-01","current":-8.352135,"twenty":-54.284211,"median":-23.884752,"eighty":-9.703863,"marketCap":81429086},{"date":"2022-07-08","current":-9.353942,"twenty":-53.734845,"median":-23.34922,"eighty":-9.444572,"marketCap":91196204},{"date":"2022-07-15","current":-8.87307,"twenty":-52.876461,"median":-22.813687,"eighty":-9.345336,"marketCap":86507939},{"date":"2022-07-22","current":-6.995425,"twenty":-52.533107,"median":-21.528409,"eighty":-9.17838,"marketCap":86477857},{"date":"2022-07-29","current":-6.86721,"twenty":-52.36143,"median":-21.04643,"eighty":-9.063888,"marketCap":84892859},{"date":"2022-08-05","current":-7.414826,"twenty":-51.8464,"median":-20.56445,"eighty":-9.010459,"marketCap":91662518},{"date":"2022-08-12","current":-7.955491,"twenty":-51.674723,"median":-20.136024,"eighty":-8.943673,"marketCap":98346243},{"date":"2022-08-19","current":-7.878253,"twenty":-51.331369,"median":-19.707598,"eighty":-8.934132,"marketCap":97391425},{"date":"2022-08-26","current":-7.204739,"twenty":-51.331369,"median":-17.565468,"eighty":-8.865634,"marketCap":89065413},{"date":"2022-09-02","current":-7.337588,"twenty":-50.644662,"median":-16.708616,"eighty":-8.847309,"marketCap":90707700},{"date":"2022-09-09","current":-8.032728,"twenty":-49.820613,"median":-16.28019,"eighty":-8.8101,"marketCap":99301061},{"date":"2022-09-16","current":-9.125301,"twenty":-45.311835,"median":-15.95887,"eighty":-8.781858,"marketCap":119352237},{"date":"2022-09-23","current":-7.920761,"twenty":-42.742456,"median":-15.530444,"eighty":-8.781858,"marketCap":103597742},{"date":"2022-09-30","current":-8.687286,"twenty":-41.56474,"median":-15.262678,"eighty":-8.69776,"marketCap":113623330},{"date":"2022-10-07","current":-10.147335,"twenty":-41.363667,"median":-14.887805,"eighty":-8.701142,"marketCap":132719688},{"date":"2022-10-14","current":-7.665253,"twenty":-40.214676,"median":-14.834252,"eighty":-8.687286,"marketCap":100255879},{"date":"2022-10-21","current":-8.030265,"twenty":-38.663538,"median":-14.566486,"eighty":-8.680534,"marketCap":105029969},{"date":"2022-10-28","current":-8.249272,"twenty":-38.232667,"median":-13.9774,"eighty":-8.576729,"marketCap":107894422},{"date":"2022-11-04","current":-7.59225,"twenty":-38.089043,"median":-12.852782,"eighty":-8.486801,"marketCap":99301061},{"date":"2022-11-11","current":-7.738255,"twenty":-37.94542,"median":-12.692122,"eighty":-8.408528,"marketCap":101210697},{"date":"2022-11-18","current":-9.214501,"twenty":-37.916695,"median":-12.638569,"eighty":-8.395566,"marketCap":120518905},{"date":"2022-11-25","current":-9.067069,"twenty":-37.830521,"median":-12.317249,"eighty":-8.392247,"marketCap":118590602},{"date":"2022-12-02","current":-8.477341,"twenty":-37.773071,"median":-12.090191,"eighty":-8.401729,"marketCap":110877392},{"date":"2022-12-09","current":-7.816845,"twenty":-37.686897,"median":-11.460397,"eighty":-8.353592,"marketCap":102238597},{"date":"2022-12-16","current":-6.430894,"twenty":-37.543273,"median":-11.367382,"eighty":-8.329909,"marketCap":80960633},{"date":"2022-12-23","current":-4.977892,"twenty":-37.399649,"median":-11.246184,"eighty":-8.295842,"marketCap":62668312},{"date":"2022-12-30","current":-4.326837,"twenty":-37.054951,"median":-11.090129,"eighty":-8.249272,"marketCap":54471964},{"date":"2023-01-06","current":-4.51526,"twenty":-36.423007,"median":-10.804356,"eighty":-8.214363,"marketCap":56844084},{"date":"2023-01-13","current":-4.542068,"twenty":-35.618713,"median":-10.564526,"eighty":-8.17627,"marketCap":57181581},{"date":"2023-01-20","current":-4.472367,"twenty":-35.618713,"median":-10.375203,"eighty":-8.119042,"marketCap":56304089},{"date":"2023-01-27","current":-5.055252,"twenty":-35.475089,"median":-10.282225,"eighty":-8.054457,"marketCap":63642231},{"date":"2023-02-03","current":-5.438226,"twenty":-35.475089,"median":-10.224241,"eighty":-8.030265,"marketCap":68463613},{"date":"2023-02-10","current":-4.673052,"twenty":-34.900594,"median":-10.147335,"eighty":-7.920761,"marketCap":58830589},{"date":"2023-02-17","current":-4.3659,"twenty":-34.75697,"median":-10.073933,"eighty":-7.878253,"marketCap":54963745},{"date":"2023-02-24","current":-3.841226,"twenty":-34.527172,"median":-9.818824,"eighty":-7.811258,"marketCap":48358453},{"date":"2023-03-03","current":-4.289305,"twenty":-34.469722,"median":-9.731754,"eighty":-7.809209,"marketCap":53999469},{"date":"2023-03-10","current":-3.837396,"twenty":-34.354823,"median":-9.703863,"eighty":-7.65286,"marketCap":48310239},{"date":"2023-03-17","current":-2.498119,"twenty":-34.0963,"median":-9.563315,"eighty":-7.541372,"marketCap":38576049},{"date":"2023-03-24","current":-2.747931,"twenty":-34.038851,"median":-9.43837,"eighty":-7.439961,"marketCap":42433654},{"date":"2023-03-31","current":-2.654252,"twenty":-33.923952,"median":-9.353942,"eighty":-7.335734,"marketCap":40987052},{"date":"2023-04-06","current":-3.076062,"twenty":-33.780328,"median":-9.323874,"eighty":-7.312254,"marketCap":47500660},{"date":"2023-04-14","current":-3.641053,"twenty":-33.607979,"median":-9.233457,"eighty":-7.191763,"marketCap":56225271},{"date":"2023-04-21","current":-3.703202,"twenty":-33.36031,"median":-9.202898,"eighty":-6.992181,"marketCap":57184979},{"date":"2023-04-28","current":-3.389318,"twenty":-32.949228,"median":-9.15675,"eighty":-6.88482,"marketCap":52337972},{"date":"2023-05-05","current":-3.20036,"twenty":-32.88986,"median":-9.133043,"eighty":-6.792337,"marketCap":49420075},{"date":"2023-05-12","current":-3.280086,"twenty":-32.88986,"median":-9.106823,"eighty":-6.016057,"marketCap":50651214},{"date":"2023-05-19","current":-3.208521,"twenty":-32.83241,"median":-9.065479,"eighty":-5.207063,"marketCap":49546097},{"date":"2023-05-26","current":-3.70383,"twenty":-32.746236,"median":-9.028587,"eighty":-5.102588,"marketCap":57194673},{"date":"2023-06-02","current":-4.852644,"twenty":-32.717511,"median":-9.019972,"eighty":-4.993364,"marketCap":74934715},{"date":"2023-06-09","current":-4.519928,"twenty":-32.602612,"median":-8.988038,"eighty":-4.818728,"marketCap":69796889},{"date":"2023-06-16","current":-4.26882,"twenty":-32.602612,"median":-8.943673,"eighty":-4.737078,"marketCap":65919284},{"date":"2023-06-23","current":-4.216716,"twenty":-32.602612,"median":-8.934132,"eighty":-4.60028,"marketCap":65114681},{"date":"2023-06-30","current":-3.135072,"twenty":-32.487714,"median":-8.906294,"eighty":-4.555493,"marketCap":48411897},{"date":"2023-07-07","current":-3.089873,"twenty":-32.114291,"median":-8.87307,"eighty":-4.518061,"marketCap":47713929},{"date":"2023-07-14","current":-3.207893,"twenty":-31.884493,"median":-8.86257,"eighty":-4.463788,"marketCap":49536403},{"date":"2023-07-21","current":-3.094895,"twenty":-31.884493,"median":-8.847309,"eighty":-4.404454,"marketCap":47791481},{"date":"2023-07-28","current":-2.949881,"twenty":-31.712144,"median":-8.826942,"eighty":-4.326481,"marketCap":45552164},{"date":"2023-08-04","current":-2.55098,"twenty":-31.597245,"median":-8.811054,"eighty":-4.299147,"marketCap":37953912},{"date":"2023-08-11","current":-2.518929,"twenty":-31.597245,"median":-8.78352,"eighty":-4.26882,"marketCap":37477051},{"date":"2023-08-18","current":-1.824367,"twenty":-31.424897,"median":-8.706103,"eighty":-4.220676,"marketCap":27143234},{"date":"2023-08-25","current":-1.791789,"twenty":-31.309998,"median":-8.693832,"eighty":-4.167979,"marketCap":26658534},{"date":"2023-09-01","current":-1.708389,"twenty":-31.223824,"median":-8.687286,"eighty":-4.122328,"marketCap":25417700},{"date":"2023-09-08","current":-1.758559,"twenty":-31.051475,"median":-8.682251,"eighty":-4.112076,"marketCap":26164139},{"date":"2023-09-15","current":-1.413526,"twenty":-30.850401,"median":-8.632916,"eighty":-4.03519,"marketCap":21724281},{"date":"2023-09-22","current":-1.443802,"twenty":-30.778589,"median":-8.586842,"eighty":-3.869413,"marketCap":22189594},{"date":"2023-09-29","current":-1.504986,"twenty":-30.735502,"median":-8.538778,"eighty":-3.70383,"marketCap":23129913},{"date":"2023-10-06","current":-1.39208,"twenty":-30.735502,"median":-8.491432,"eighty":-3.68462,"marketCap":21394685},{"date":"2023-10-13","current":-1.368742,"twenty":-30.678053,"median":-8.47281,"eighty":-3.559819,"marketCap":21036006},{"date":"2023-10-20","current":-1.281698,"twenty":-30.591879,"median":-8.418917,"eighty":-3.467663,"marketCap":19698233},{"date":"2023-10-27","current":-1.157439,"twenty":-30.591879,"median":-8.410939,"eighty":-3.38982,"marketCap":17788512},{"date":"2023-11-03","current":-0.693833,"twenty":-30.591879,"median":-8.398885,"eighty":-3.331814,"marketCap":10663418},{"date":"2023-11-10","current":-0.593332,"twenty":-30.41953,"median":-8.366706,"eighty":-3.275817,"marketCap":9118838},{"date":"2023-11-17","current":-0.622347,"twenty":-30.132282,"median":-8.340685,"eighty":-3.256733,"marketCap":9564763},{"date":"2023-11-24","current":-0.434255,"twenty":-29.730135,"median":-8.329909,"eighty":-3.228484,"marketCap":6674007},{"date":"2023-12-01","current":-0.508811,"twenty":-29.184365,"median":-8.322274,"eighty":-3.207893,"marketCap":7819840},{"date":"2023-12-08","current":-0.46676,"twenty":-28.782218,"median":-8.256193,"eighty":-3.200862,"marketCap":7173572},{"date":"2023-12-15","current":-0.44153,"twenty":-28.437521,"median":-8.249272,"eighty":-3.173299,"marketCap":6785811},{"date":"2023-12-22","current":-0.422596,"twenty":-28.265172,"median":-8.247184,"eighty":-3.143861,"marketCap":6408632},{"date":"2023-12-29","current":-0.417901,"twenty":-28.006649,"median":-8.200897,"eighty":-3.135072,"marketCap":6337425},{"date":"2024-01-05","current":-0.458799,"twenty":-27.847012,"median":-8.187204,"eighty":-3.104688,"marketCap":6957638},{"date":"2024-01-12","current":-0.436683,"twenty":-27.469353,"median":-8.17627,"eighty":-3.069716,"marketCap":6622253},{"date":"2024-01-19","current":-0.427292,"twenty":-27.212297,"median":-8.147656,"eighty":-3.03149,"marketCap":6479839},{"date":"2024-01-26","current":-0.394087,"twenty":-26.755207,"median":-8.103267,"eighty":-2.950555,"marketCap":5976289},{"date":"2024-02-02","current":-0.379327,"twenty":-26.026883,"median":-8.043592,"eighty":-2.78146,"marketCap":5752450},{"date":"2024-02-09","current":-0.410266,"twenty":-24.977239,"median":-8.032728,"eighty":-2.722825,"marketCap":6221640},{"date":"2024-02-16","current":-0.385301,"twenty":-23.670539,"median":-8.030265,"eighty":-2.666243,"marketCap":5843046},{"date":"2024-02-23","current":-0.384515,"twenty":-23.34922,"median":-7.938126,"eighty":-2.615329,"marketCap":5831132},{"date":"2024-03-01","current":-0.399835,"twenty":-23.284956,"median":-7.88426,"eighty":-2.524663,"marketCap":6063451},{"date":"2024-03-08","current":-0.46264,"twenty":-22.985057,"median":-7.85091,"eighty":-2.242859,"marketCap":7015891},{"date":"2024-03-15","current":-0.423359,"twenty":-22.813687,"median":-7.811258,"eighty":-1.890175,"marketCap":6420203},{"date":"2024-03-22","current":-0.458276,"twenty":-22.749423,"median":-7.811258,"eighty":-1.82567,"marketCap":6949704},{"date":"2024-03-28","current":-0.564774,"twenty":-22.492368,"median":-7.806136,"eighty":-1.823064,"marketCap":7004182},{"date":"2024-04-05","current":-0.49833,"twenty":-21.528409,"median":-7.738255,"eighty":-1.759211,"marketCap":6180161},{"date":"2024-04-12","current":-0.494177,"twenty":-21.314196,"median":-7.597768,"eighty":-1.513816,"marketCap":6128660},{"date":"2024-04-19","current":-0.382607,"twenty":-21.099983,"median":-7.546903,"eighty":-1.494894,"marketCap":4744990},{"date":"2024-04-26","current":-0.38759,"twenty":-20.992877,"median":-7.495539,"eighty":-1.443802,"marketCap":4806792},{"date":"2024-05-03","current":-0.406969,"twenty":-20.778664,"median":-7.414826,"eighty":-1.422987,"marketCap":5047131},{"date":"2024-05-10","current":-0.326683,"twenty":-20.56445,"median":-7.340087,"eighty":-1.386403,"marketCap":4051439},{"date":"2024-05-17","current":-0.360039,"twenty":-20.350237,"median":-7.327547,"eighty":-1.331528,"marketCap":4465116},{"date":"2024-05-24","current":-0.329749,"twenty":-20.350237,"median":-7.245289,"eighty":-1.311974,"marketCap":4089461},{"date":"2024-05-31","current":-0.350903,"twenty":-20.007496,"median":-7.193926,"eighty":-1.267695,"marketCap":4351810},{"date":"2024-06-07","current":-0.344956,"twenty":-19.750441,"median":-7.067256,"eighty":-1.032675,"marketCap":4278051},{"date":"2024-06-14","current":-0.270314,"twenty":-19.707598,"median":-6.985384,"eighty":-0.73363,"marketCap":3352369},{"date":"2024-06-21","current":-0.249795,"twenty":-19.386279,"median":-6.922821,"eighty":-0.678695,"marketCap":3097899},{"date":"2024-06-28","current":-0.23457,"twenty":-18.336635,"median":-6.85099,"eighty":-0.605695,"marketCap":2909074},{"date":"2024-07-05","current":-0.232488,"twenty":-17.608311,"median":-6.83991,"eighty":-0.576932,"marketCap":2883259},{"date":"2024-07-12","current":-0.265612,"twenty":-17.351255,"median":-6.404852,"eighty":-0.543277,"marketCap":3294056},{"date":"2024-07-19","current":-0.239418,"twenty":-17.094199,"median":-5.859497,"eighty":-0.509547,"marketCap":2969207},{"date":"2024-07-26","current":-0.245211,"twenty":-16.580088,"median":-5.270484,"eighty":-0.495838,"marketCap":3041043},{"date":"2024-08-02","current":-0.275684,"twenty":-16.344454,"median":-5.200016,"eighty":-0.489306,"marketCap":2742439},{"date":"2024-08-09","current":-0.180548,"twenty":-16.237347,"median":-5.107337,"eighty":-0.487256,"marketCap":1796045},{"date":"2024-08-16","current":-0.172506,"twenty":-16.173083,"median":-5.055252,"eighty":-0.469552,"marketCap":1716043},{"date":"2024-08-23","current":-0.260463,"twenty":-16.001713,"median":-4.885013,"eighty":-0.465618,"marketCap":2591016},{"date":"2024-08-30","current":-0.19873,"twenty":-15.701815,"median":-4.815511,"eighty":-0.461152,"marketCap":1976911},{"date":"2024-09-06","current":-0.179279,"twenty":-15.61613,"median":-4.742746,"eighty":-0.458291,"marketCap":1783426},{"date":"2024-09-13","current":-1.01534,"twenty":-15.509023,"median":-4.725895,"eighty":-0.458276,"marketCap":7507818},{"date":"2024-09-20","current":-0.88908,"twenty":-15.401917,"median":-4.60028,"eighty":-0.458291,"marketCap":6574203},{"date":"2024-09-27","current":-0.931166,"twenty":-15.29481,"median":-4.568075,"eighty":-0.45844,"marketCap":6885408},{"date":"2024-10-04","current":-1.004693,"twenty":-15.166282,"median":-4.527515,"eighty":-0.459071,"marketCap":7429094},{"date":"2024-10-11","current":-1.004693,"twenty":-14.973491,"median":-4.504919,"eighty":-0.460656,"marketCap":7429094},{"date":"2024-10-18","current":-1.013772,"twenty":-14.887805,"median":-4.472367,"eighty":-0.46264,"marketCap":7496225},{"date":"2024-10-25","current":-0.974431,"twenty":-14.887805,"median":-4.442112,"eighty":-0.462971,"marketCap":7205326},{"date":"2024-11-01","current":-0.995615,"twenty":-14.866384,"median":-4.3659,"eighty":-0.464406,"marketCap":7361964},{"date":"2024-11-08","current":-0.901803,"twenty":-14.780699,"median":-4.340624,"eighty":-0.465237,"marketCap":6668283},{"date":"2024-11-15","current":-0.823122,"twenty":-14.737856,"median":-4.320297,"eighty":-0.466809,"marketCap":6086487},{"date":"2024-11-22","current":-0.79286,"twenty":-14.523643,"median":-4.299038,"eighty":-0.467514,"marketCap":5862719},{"date":"2024-11-29","current":-0.786808,"twenty":-14.352273,"median":-4.289305,"eighty":-0.469552,"marketCap":5817965},{"date":"2024-12-06","current":-0.68997,"twenty":-14.245166,"median":-4.26882,"eighty":-0.469552,"marketCap":5101908},{"date":"2024-12-13","current":-1.105148,"twenty":-13.709634,"median":-4.224965,"eighty":-0.470645,"marketCap":6465027},{"date":"2024-12-20","current":-1.030852,"twenty":-13.281208,"median":-4.217971,"eighty":-0.470965,"marketCap":6030403},{"date":"2024-12-27","current":-1.114435,"twenty":-12.938467,"median":-4.174413,"eighty":-0.483998,"marketCap":6519355},{"date":"2025-01-03","current":-1.170156,"twenty":-12.788518,"median":-4.153732,"eighty":-0.487256,"marketCap":6845323},{"date":"2025-01-10","current":-1.049426,"twenty":-12.745675,"median":-4.125392,"eighty":-0.487256,"marketCap":6139060},{"date":"2025-01-17","current":-1.077287,"twenty":-12.702833,"median":-4.112754,"eighty":-0.487884,"marketCap":6302043},{"date":"2025-01-24","current":-1.086574,"twenty":-12.638569,"median":-4.102462,"eighty":-0.488827,"marketCap":6356371},{"date":"2025-01-31","current":-1.05407,"twenty":-12.638569,"median":-4.059521,"eighty":-0.489066,"marketCap":6166224},{"date":"2025-02-07","current":-1.058713,"twenty":-12.606134,"median":-4.000803,"eighty":-0.490035,"marketCap":6193388},{"date":"2025-02-14","current":-1.012278,"twenty":-12.444566,"median":-3.841226,"eighty":-0.490462,"marketCap":5921747},{"date":"2025-02-21","current":-0.889319,"twenty":-12.317249,"median":-3.766606,"eighty":-0.491991,"marketCap":5202445},{"date":"2025-02-28","current":-0.924791,"twenty":-12.317249,"median":-3.703516,"eighty":-0.494177,"marketCap":5409953},{"date":"2025-03-07","current":-0.857123,"twenty":-12.29156,"median":-3.68688,"eighty":-0.49471,"marketCap":5014103},{"date":"2025-03-14","current":-1.05699,"twenty":-11.888823,"median":-3.6588,"eighty":-0.49833,"marketCap":4467829},{"date":"2025-03-21","current":-1.576432,"twenty":-11.737053,"median":-3.547515,"eighty":-0.503313,"marketCap":6663479},{"date":"2025-03-28","current":-1.654473,"twenty":-11.460397,"median":-3.517069,"eighty":-0.505711,"marketCap":6993354},{"date":"2025-04-04","current":-1.533822,"twenty":-11.4598,"median":-3.389946,"eighty":-0.508811,"marketCap":6483367},{"date":"2025-04-11","current":-1.197464,"twenty":-11.367382,"median":-3.343805,"eighty":-0.51065,"marketCap":5061605},{"date":"2025-04-17","current":-1.045752,"twenty":-11.367382,"median":-3.311475,"eighty":-0.514141,"marketCap":4420327},{"date":"2025-04-25","current":-1.06136,"twenty":-11.293448,"median":-3.280086,"eighty":-0.521998,"marketCap":4486302},{"date":"2025-05-02","current":-1.045752,"twenty":-11.25194,"median":-3.263764,"eighty":-0.535975,"marketCap":4420327},{"date":"2025-05-09","current":-1.027178,"twenty":-11.246184,"median":-3.24807,"eighty":-0.547521,"marketCap":4341817},{"date":"2025-05-16","current":-0.589644,"twenty":-11.12134,"median":-3.229551,"eighty":-0.552889,"marketCap":2492390},{"date":"2025-05-23","current":-0.617392,"twenty":-10.868327,"median":-3.208521,"eighty":-0.562559,"marketCap":2609679},{"date":"2025-05-30","current":-0.943431,"twenty":-10.807764,"median":-3.207893,"eighty":-0.56825,"marketCap":3987824},{"date":"2025-06-06","current":-0.64514,"twenty":-10.754017,"median":-3.201615,"eighty":-0.571359,"marketCap":2726968},{"date":"2025-06-13","current":-0.553225,"twenty":-10.699691,"median":-3.194082,"eighty":-0.571359,"marketCap":2338448},{"date":"2025-06-20","current":-0.523743,"twenty":-10.58879,"median":-3.176505,"eighty":-0.556978,"marketCap":2213829},{"date":"2025-06-27","current":-0.5064,"twenty":-10.425771,"median":-3.160811,"eighty":-0.537143,"marketCap":2140523},{"date":"2025-07-03","current":-0.509869,"twenty":-10.389853,"median":-3.144175,"eighty":-0.523743,"marketCap":2155184},{"date":"2025-07-11","current":-0.529834,"twenty":-10.339297,"median":-3.135072,"eighty":-0.515026,"marketCap":2239575},{"date":"2025-07-18","current":-0.648049,"twenty":-10.291116,"median":-3.103056,"eighty":-0.516806,"marketCap":2739262},{"date":"2025-07-25","current":-1.918187,"twenty":-10.277454,"median":-3.085135,"eighty":-0.523743,"marketCap":8660331},{"date":"2025-08-01","current":-1.443452,"twenty":-10.258369,"median":-3.058005,"eighty":-0.524438,"marketCap":6516972},{"date":"2025-08-08","current":-1.561288,"twenty":-10.244718,"median":-3.022702,"eighty":-0.527736,"marketCap":7048987},{"date":"2025-08-15","current":-1.689947,"twenty":-10.185282,"median":-2.971112,"eighty":-0.530181,"marketCap":7629862},{"date":"2025-08-22","current":-1.634311,"twenty":-10.162229,"median":-2.850354,"eighty":-0.532433,"marketCap":7378673},{"date":"2025-08-29","current":-1.689947,"twenty":-10.140546,"median":-2.786281,"eighty":-0.536513,"marketCap":7629862},{"date":"2025-09-05","current":-1.578675,"twenty":-10.113391,"median":-2.741998,"eighty":-0.539033,"marketCap":7127484},{"date":"2025-09-12","current":-1.207034,"twenty":-10.074332,"median":-2.718578,"eighty":-0.549643,"marketCap":7535666},{"date":"2025-09-19","current":-1.252298,"twenty":-10.073534,"median":-2.684653,"eighty":-0.553225,"marketCap":7818253},{"date":"2025-09-26","current":-1.186917,"twenty":-9.855325,"median":-2.654252,"eighty":-0.5537,"marketCap":7410071},{"date":"2025-10-03","current":-1.242239,"twenty":-9.782322,"median":-2.582193,"eighty":-0.561896,"marketCap":7755456},{"date":"2025-10-10","current":-1.283792,"twenty":-9.731754,"median":-2.547598,"eighty":-0.564774,"marketCap":8014876},{"date":"2025-10-16","current":-1.278282,"twenty":-9.731754,"median":-2.498119,"eighty":-0.569409,"marketCap":7980477}],"updateTime":1760761516429},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALZN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574912581","title":"Alzamend Neuro Inc Issues 361743 Shares of Common Stock Upon Conversion of Series B Preferred","url":"https://stock-news.laohu8.com/highlight/detail?id=2574912581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574912581?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:31","pubTimestamp":1760041870,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. issued a total of 361,743 shares of common stock between October 1 and October 8, 2025, upon conversion of approximately 839.2 shares of Series B Convertible Preferred Stock. The shares were issued in reliance on an exemption from registration requirements under Section 4 of the Securities Act. The other party to the transaction was holders of the Series B Convertible Preferred Stock. The price per share was not disclosed in the document. As of October 8, 2025, Alzamend Neuro had 3,801,604 shares of common stock outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retriev","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nNDL9K4x6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4539","BK4139"],"gpt_icon":0},{"id":"2572304861","title":"Director’s Major Stock Sale Shakes Up Alzamend Neuro!","url":"https://stock-news.laohu8.com/highlight/detail?id=2572304861","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572304861?lang=en_us&edition=fundamental","pubTime":"2025-10-01 10:04","pubTimestamp":1759284241,"startTime":"0","endTime":"0","summary":"New insider activity at Alzamend Neuro ( ($ALZN) ) has taken place on September 30, 2025. Director Milton C III Ault has recently sold 79,628 share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/directors-major-stock-sale-shakes-up-alzamend-neuro-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/directors-major-stock-sale-shakes-up-alzamend-neuro-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","ALZN"],"gpt_icon":0},{"id":"2572308421","title":"Alzamend Neuro Inc. Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572308421","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572308421?lang=en_us&edition=fundamental","pubTime":"2025-10-01 07:15","pubTimestamp":1759274154,"startTime":"0","endTime":"0","summary":"Milton C. Ault III, a director and 10% owner, reported a disposal of common shares of Alzamend Neuro Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL3sFwcN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2570494110","title":"Alzamend Neuro Inc. Issues 300,000 Common Shares Upon Conversion of Series B Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2570494110","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570494110?lang=en_us&edition=fundamental","pubTime":"2025-09-26 04:31","pubTimestamp":1758832297,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. has issued a total of 300,000 shares of common stock between September 17 and September 25, 2025, following the conversion of 696 shares of Series B Convertible Preferred Stock. The shares were issued privately under an exemption from SEC registration. As of September 25, 2025, the company had 3,439,861 shares of common stock outstanding. The document does not disclose the other party involved or the transaction price.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 25, 2025, and is solely res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL6ccH7z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2570092191","title":"Alzamend Neuro Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2570092191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570092191?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:12","pubTimestamp":1758802320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALZN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 25, 2025 08:12 ET (12:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2570660810","title":"U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2570660810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570660810?lang=en_us&edition=fundamental","pubTime":"2025-09-25 15:27","pubTimestamp":1758785232,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern TrustSept 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nL3N3VC0H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSRM","BP","GNRC","FHB","OZK","SSB","FHN","WBS","ACAD","RNST","STT","CTAS","EWBC","WLK","APGE","MVBF","AUB","FLG","MKC","COLB","HL","FCX","VLY","WTFC","CUBI","LOB","WOR","ZION","HRMY","BK","EBC","ALZN","GH","CFR","WAL","CMA","NTRS","KBH","PNFP","CBSH","INTC","WSFS","CCB","UMBF","BDX","PB","ONB","MNPR"],"gpt_icon":1},{"id":"2570548950","title":"Alzamend Neuro Inc : Ascendiant Capital Markets Cuts Target Price to $42 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2570548950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570548950?lang=en_us&edition=fundamental","pubTime":"2025-09-25 11:54","pubTimestamp":1758772440,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nFWN3VB0ZC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALZN","BK4539","BK4139"],"gpt_icon":0},{"id":"2569746386","title":"Director and 10% Owner Milton C III Ault Reports Disposal of Alzamend Neuro Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2569746386","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569746386?lang=en_us&edition=fundamental","pubTime":"2025-09-24 04:31","pubTimestamp":1758659489,"startTime":"0","endTime":"0","summary":"Milton C. Ault III, a Director and 10% Owner of Alzamend Neuro Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLbTlTG0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4139","BK4539"],"gpt_icon":0},{"id":"2567909903","title":"Maxim Group Sticks to Their Hold Rating for Alzamend Neuro (ALZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567909903","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567909903?lang=en_us&edition=fundamental","pubTime":"2025-09-13 00:05","pubTimestamp":1757693150,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Michael Okunewitch from Maxim Group maintained a Hold rating on Alzamend Neuro. The company’s shares opened today a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-alzamend-neuro-alzn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-alzamend-neuro-alzn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALZN"],"gpt_icon":0},{"id":"2566987895","title":"Alzamend Neuro Q1 EPS $(1.28) Misses $(0.69) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2566987895","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566987895?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:41","pubTimestamp":1757536917,"startTime":"0","endTime":"0","summary":"Alzamend Neuro (NASDAQ:ALZN) reported quarterly losses of $(1.28) per share which missed the analyst consensus estimate of $(0.69) by 85.51 percent. This is a 88.79 percent increase over losses of $(11.42) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/09/47609579/alzamend-neuro-q1-eps-1-28-misses-0-69-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alzamend Neuro Q1 EPS $(1.28) Misses $(0.69) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2566982139","title":"Alzamend Neuro Inc. Reports No Revenue for Quarter Ending July 31, 2025; Net Loss Per Share at $1.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2566982139","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566982139?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:31","pubTimestamp":1757536315,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. released its quarterly financial results for the period ending July 31, 2025. The company did not report any revenue for this quarter, consistent with the same period in 2024, as its product candidates AL001 and ALZN002 are still in the clinical stage of development. The net loss per common share was reported at $1.28, based on a basic and diluted weighted average of 2.1 million common shares outstanding. This is a decrease compared to a net loss per common share of $11.42 in the previous period, which was based on a lower average of 85,314 common shares outstanding. The company does not anticipate generating revenue in the foreseeable future as its product candidates require extensive development, regulatory approval, and significant investment before they can be marketed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL3M07zn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2565593538","title":"Alzamend Neuro Inc  expected to post a loss of 69 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2565593538","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565593538?lang=en_us&edition=fundamental","pubTime":"2025-09-06 04:16","pubTimestamp":1757103369,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc  expected to post a loss of69cents a share - Earnings Preview Alzamend Neuro Inc ALZN.OQ ALZN.O is expected to  show no change in quarterly revenue when it reports  results on Septe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL8N3US1CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2561463091","title":"Alzamend Neuro Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2561463091","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561463091?lang=en_us&edition=fundamental","pubTime":"2025-08-21 17:42","pubTimestamp":1755769320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALZN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 05:42 ET (09:42 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2556845700","title":"Alzamend Neuro Inc. Issues 243,429 Shares of Common Stock in Conversion of Series B Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2556845700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556845700?lang=en_us&edition=fundamental","pubTime":"2025-08-02 04:31","pubTimestamp":1754080297,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. recently issued 243,429 shares of common stock upon the conversion of approximately 564.76 shares of Series B Convertible Preferred Stock. These transactions occurred between July 23 and July 30, 2025, under an exemption from registration requirements as per Section 4 of the Securities Act. As of July 30, 2025, the company had a total of 3,139,861 shares of common stock outstanding. The document does not disclose the other party involved in the transaction or the price of the shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL1y48S6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ALZN"],"gpt_icon":0},{"id":"2555061105","title":"Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares of Alzamend Neuro Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2555061105","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555061105?lang=en_us&edition=fundamental","pubTime":"2025-07-30 04:56","pubTimestamp":1753822574,"startTime":"0","endTime":"0","summary":"Milton C. Ault III, a director and 10% owner of Alzamend Neuro, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDL6k520P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2554779242","title":"Alzamend Neuro to Present at the 2025 Military Health System Research Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779242","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779242?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:00","pubTimestamp":1753704000,"startTime":"0","endTime":"0","summary":"Session Topic is the Innovation and Current Directions in Military Suicide Prevention, Research, and ProgramsPresentation Title is Quantitate Differences in Lithium Brain-to-Plasma Exposure in PTSD Su","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/28/3122431/0/en/Alzamend-Neuro-to-Present-at-the-2025-Military-Health-System-Research-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","ALZN","BK4139","BK4539"],"gpt_icon":0},{"id":"2553248885","title":"Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2553248885","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553248885?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:00","pubTimestamp":1753272000,"startTime":"0","endTime":"0","summary":"During the year ended April 30, 2025, net cash provided by financing activities was $10.4 millionStockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cashIn May 2025, Alzame","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/23/3120190/0/en/Alzamend-Neuro-Reports-Annual-2025-Financial-Results-and-Provides-Update-on-Clinical-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4139","ABVC"],"gpt_icon":0},{"id":"2553265138","title":"Alzamend Neuro Inc. Reports No Revenue, Net Loss Narrows by 49.9%, EPS Improves by $121.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2553265138","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553265138?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:31","pubTimestamp":1753216297,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. released its financial results for the fiscal year ending April 30, 2025. The company reported a net loss attributable to common shares of approximately $4.99 million, a decrease from the previous year's net loss of about $9.95 million, reflecting a 49.9% improvement. Total operating expenses were $4.50 million, down 55% from $9.94 million the prior year. Research and development expenses significantly decreased by 78% to $1.41 million from $6.46 million, while general and administrative expenses also saw a reduction of 12% to $3.08 million from $3.48 million. The company's product candidates, AL001 and ALZN002, remain in the clinical stage of development, requiring further study, evaluation, and regulatory approval before generating revenue. Alzamend Neuro Inc. continues to advance the clinical development of AL001 for the treatment of Alzheimer's, BD, MDD, and PTSD, as well as ALZN002 for Alzheimer's treatment. The company is also focused on expanding its pipeline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL99Q9dl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2550663971","title":"Alzamend Neuro Inc. Eliminates Series A Preferred Stock in Bylaw Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663971","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663971?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:31","pubTimestamp":1752093076,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. announced an amendment to its bylaws with the filing of a Certificate of Elimination for its Series A convertible preferred stock. This filing effectively removes all matters related to the Series A Preferred Stock from the company's Certificate of Incorporation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL82XpxB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4139","BK4539"],"gpt_icon":0},{"id":"2543672852","title":"Press Release: Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2543672852","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543672852?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:00","pubTimestamp":1750075200,"startTime":"0","endTime":"0","summary":"ATLANTA, June 16, 2025  -- Alzamend Neuro, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease , bipolar disorder , major depressive disorder  and post-traumatic stress disorder , today announced that it has completed the final closing of its $5 million private placement.On Friday, June 13, 2025, the Investor purchased the remaining available shares of Preferred Stock in the Financing, months ahead of the originally scheduled final Tranche Closing in October 2025. With $5 million in gross proceeds from this Financing received, Alzamend's financial position is significantly increased, and Alzamend would receive additional proceeds should the Investor exercise the Warrants.Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's, BD, MDD and PTSD. Our mission is to rapidly develop and market safe and effective treatments. Our current pipel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","ABVC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}